<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p87" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_87{left:130px;bottom:1195px;letter-spacing:0.22px;}
#t2_87{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_87{left:238px;bottom:1115px;letter-spacing:-0.01px;}
#t4_87{left:238px;bottom:1096px;letter-spacing:-0.01px;}
#t5_87{left:238px;bottom:1076px;letter-spacing:-0.01px;}
#t6_87{left:238px;bottom:1057px;letter-spacing:-0.01px;}
#t7_87{left:238px;bottom:1037px;letter-spacing:-0.01px;}
#t8_87{left:238px;bottom:983px;letter-spacing:-0.01px;}
#t9_87{left:238px;bottom:964px;letter-spacing:-0.01px;}
#ta_87{left:238px;bottom:944px;letter-spacing:-0.01px;}
#tb_87{left:238px;bottom:925px;letter-spacing:-0.01px;}
#tc_87{left:238px;bottom:906px;letter-spacing:-0.01px;}
#td_87{left:238px;bottom:886px;letter-spacing:-0.01px;}
#te_87{left:238px;bottom:867px;letter-spacing:-0.01px;}
#tf_87{left:238px;bottom:847px;letter-spacing:-0.01px;}
#tg_87{left:238px;bottom:793px;letter-spacing:-0.01px;}
#th_87{left:238px;bottom:774px;letter-spacing:-0.01px;}
#ti_87{left:238px;bottom:754px;letter-spacing:-0.01px;}
#tj_87{left:238px;bottom:735px;letter-spacing:-0.01px;}
#tk_87{left:238px;bottom:715px;letter-spacing:-0.01px;}
#tl_87{left:238px;bottom:696px;letter-spacing:-0.01px;}
#tm_87{left:128px;bottom:623px;letter-spacing:0.16px;}
#tn_87{left:238px;bottom:623px;letter-spacing:-0.18px;}
#to_87{left:258px;bottom:593px;letter-spacing:-0.19px;}
#tp_87{left:141px;bottom:559px;letter-spacing:-0.01px;}
#tq_87{left:248px;bottom:560px;letter-spacing:0.25px;}
#tr_87{left:143px;bottom:502px;letter-spacing:-0.29px;}
#ts_87{left:250px;bottom:522px;letter-spacing:-0.01px;}
#tt_87{left:250px;bottom:503px;letter-spacing:-0.01px;}
#tu_87{left:250px;bottom:484px;letter-spacing:-0.01px;}
#tv_87{left:248px;bottom:428px;letter-spacing:-0.04px;}
#tw_87{left:141px;bottom:351px;letter-spacing:-0.01px;}
#tx_87{left:248px;bottom:351px;letter-spacing:0.25px;}
#ty_87{left:143px;bottom:294px;letter-spacing:-0.29px;}
#tz_87{left:250px;bottom:314px;letter-spacing:-0.01px;}
#t10_87{left:250px;bottom:294px;letter-spacing:-0.01px;}
#t11_87{left:248px;bottom:259px;letter-spacing:-0.04px;}
#t12_87{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_87{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_87{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_87{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_87{font-size:21px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_87{font-size:28px;font-family:NotoSans-Regular_7j-;color:#000;}
.s5_87{font-size:10px;font-family:NotoSans-Regular_7j-;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts87" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg87Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg87" style="-webkit-user-select: none;"><object width="908" height="1286" data="87/87.svg" type="image/svg+xml" id="pdf87" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_87" class="t s0_87">7.7. Residual tumor, recurrence and recurrent metastasis </span><span id="t2_87" class="t s1_87">87 </span>
<span id="t3_87" class="t s2_87">Stages. Complete organ resection generally requires reconstruction of the esophagus. The </span>
<span id="t4_87" class="t s2_87">first choice method for this is a forearm transplant. It is important to plan the transplant to </span>
<span id="t5_87" class="t s2_87">be wide enough to be able to model the widest possible tube. To prevent postoperative </span>
<span id="t6_87" class="t s2_87">stenosis, the lower anastomosis with the esophageal entrance should be dissolved by </span>
<span id="t7_87" class="t s2_87">triangular exchange. </span>
<span id="t8_87" class="t s2_87">Another variant of stenosis prophylaxis with simultaneous formation of a very wide </span>
<span id="t9_87" class="t s2_87">neohypopharynx was described by Bootz et al. [291]. The forearm transplant is sewn with the </span>
<span id="ta_87" class="t s2_87">longitudinal edges in a U-shape onto the prevertebral fascia. This reduces shrinkage and </span>
<span id="tb_87" class="t s2_87">stenosis to a minimum. Alternatively, reconstruction can also be carried out using pedicled </span>
<span id="tc_87" class="t s2_87">flaps. This is recommended in cases of poor vascular positioning, extensive resection and as </span>
<span id="td_87" class="t s2_87">part of salvager resections after primary radiochemotherapy. Voice rehabilitation is carried </span>
<span id="te_87" class="t s2_87">out with voice prostheses that are placed below the caudal anastomosis in the anterior wall of </span>
<span id="tf_87" class="t s2_87">the esophagus. </span>
<span id="tg_87" class="t s2_87">An alternative to voice rehabilitation that is now only used very rarely is the construction of a </span>
<span id="th_87" class="t s2_87">speech siphon with simultaneous reconstruction of the esophagus from extra-long jejunal </span>
<span id="ti_87" class="t s2_87">segments and was also described by Remmert et al. [292, 293]. Because of the necessary </span>
<span id="tj_87" class="t s2_87">abdominal surgery, the procedure is primarily suitable for younger patients and has the </span>
<span id="tk_87" class="t s2_87">advantage of a very short rehabilitation period of just a few weeks to regain swallowing and </span>
<span id="tl_87" class="t s2_87">voice function. </span>
<span id="tm_87" class="t s3_87">7.7. </span><span id="tn_87" class="t s3_87">Residual tumor, recurrence and recurrent </span>
<span id="to_87" class="t s3_87">metastasis </span>
<span id="tp_87" class="t s2_87">7.55. </span><span id="tq_87" class="t s0_87">Consensus-based recommendation </span>
<span id="tr_87" class="t s4_87">EEC </span>
<span id="ts_87" class="t s2_87">If local or locoregional recurrences occur, the possibility of repeat surgery and/or radio- or </span>
<span id="tt_87" class="t s2_87">chemoradiotherapy should be reviewed depending on the previous therapy and the extent </span>
<span id="tu_87" class="t s2_87">of the recurrence. </span>
<span id="tv_87" class="t s5_87">Strong consensus: 100% </span>
<span id="tw_87" class="t s2_87">7.56. </span><span id="tx_87" class="t s0_87">Consensus-based recommendation </span>
<span id="ty_87" class="t s4_87">EEC </span>
<span id="tz_87" class="t s2_87">If a locoregional tumor residue (M0) exists after primary radiochemotherapy, the possibility </span>
<span id="t10_87" class="t s2_87">of salvage surgery should be examined. </span>
<span id="t11_87" class="t s5_87">Strong consensus: 100% </span>
<span id="t12_87" class="t s0_87">Â© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
